Refine Search

Not enough evidence about tamoxifen

LONDON -- Contradicting U.S. findings, British scientists who conducted the longest-running study of tamoxifen have concluded there is not enough evidence the drug prevents breast cancer, according to research published Friday. Although scientists agree tamoxifen fights the recurrence of breast cancer in women who already have had surgery, they are divided over whether it prevents the disease from occurring in the first place.
XXX Technology